Orion Therapeutics-preview

Orionthx

Orion Therapeutics

Private

Knoxville, TennesseeHealthcare & Life Scienceshttps://orionthx.com/

Last Round

Grant

Sep 15, 2025

Total Funding Raised

$2.03M

Momentum Score

50 /100

Company Overview

Orion Therapeutics is a biotechnology company that develops RNA therapies and vaccines enabled by a novel delivery platform.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Platform-as-a-Service, Precision Medicine

Business Model

B2B

Customer Profile

Revenue Share, Services & Consulting, Government Contracts

AI Layer

Non-AI

Keywords

lipid nanoparticle deliveryLNP deliveryRNA deliveryplatform biotechdrug delivery vehicleextra-hepatic deliverysiRNA therapeuticsnon-viral deliverynucleic acid deliveryrestenosis treatmentbiotech platform licensinglow immunogenicitypreclinical servicesSmall Business Technology TransferSTTR

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Orion Therapeutics Comps

Public and private peers based on sector, stage, and business model.

Company	Status	Est. Valuation	Rev Multiple
OpenAI	Private	$86.0B	~40x
Cohere	Private	$5.0B	--
Competitor 1	Public	$XX.XB	XXx
Competitor 2	Public	$XX.XB	XXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Orion Therapeutics Funding Rounds

Historical fundraising activity

Round	Date	Amount Raised	Valuation	Investors	Sources
Grant	Sep 15, 2025
Pre Seed	Jul 9, 2024
Grant	Oct 24, 2023
Grant	Sep 12, 2023
Grant	May 4, 2023
Accelerator	Sep 26, 2022

View all Funding Rounds

Key People

Founding team and executive leadership

Trey Fisher

President And CEO

Executive Team

Orion Therapeutics Investors

Notable investors and investment history

Investor	Rounds
Tennessee Technology Development Corporation	Pre Seed, Grant
Nucleate	Grant
University of Tennessee Research Foundation	Pre Seed
National Science Foundation	Grant

View all Investors

Market signals

Structured signals derived from secondary market and firmographic data.

Apr 15, 2026
Monthly visitors grew 98% MoM, reaching 1.2K.
Sep 15, 2025
$1.25M grant from the National Science Foundation

View all signals

Orion Therapeutics Filings

SEC and related filings with document metadata.

Typed	Date	Amount Offered	Amount Sold	Filling	Pages	Download
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation

Orion Therapeutics Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Orion Therapeutics's valuation, stock price, and market status.

Firmographic Details

HeadquartersKnoxville, Tennessee

Employee Range8

Year Founded2022

Last FundingSep 15, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.